Comparative effectiveness of tirzepatide and semaglutide for obesity management in US clinical practice: a 6-month retrospective cohort study - PubMed
3 months ago
- #Real-world Evidence
- #Comparative Effectiveness
- #Obesity
- Comparative effectiveness study of tirzepatide and semaglutide for obesity management in US clinical practice.
- 6-month retrospective cohort study design.
- Funded by Eli Lilly and Company, with some authors being employees of Eli Lilly or Analysis Group, Inc.
- Data sourced from Truveta, with restrictions on public deposition due to licensing agreements.
- Study considered exempt research under HIPAA regulations for de-identified data use.
- Multiple conflicts of interest disclosed, including consulting fees, stock options, and advisory roles related to pharmaceutical companies.